Insider Transactions in Q3 2025 at Lb Pharmaceuticals Inc (LBRX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2025
|
Deep Track Biotechnology Master Fund, Ltd. |
BUY
Open market or private purchase
|
Indirect |
666,666
+50.0%
|
$9,999,990
$15.0 P/Share
|
|
Sep 12
2025
|
Deep Track Biotechnology Master Fund, Ltd. |
BUY
Open market or private purchase
|
Direct |
2,000,000
+42.68%
|
$30,000,000
$15.0 P/Share
|
|
Sep 12
2025
|
Deep Track Biotechnology Master Fund, Ltd. |
BUY
Conversion of derivative security
|
Direct |
686,138
+50.0%
|
-
|
|
Sep 12
2025
|
Ran Nussbaum |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+41.46%
|
$15,000,000
$15.0 P/Share
|
|
Sep 12
2025
|
Ran Nussbaum |
BUY
Conversion of derivative security
|
Indirect |
411,681
+50.0%
|
-
|
|
Sep 12
2025
|
Pontifax Management 4 G.P. (2015) Ltd. |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+41.46%
|
$15,000,000
$15.0 P/Share
|
|
Sep 12
2025
|
Pontifax Management 4 G.P. (2015) Ltd. |
BUY
Conversion of derivative security
|
Indirect |
411,681
+50.0%
|
-
|
|
Sep 12
2025
|
Vida Ventures Gp Iii, L.L.C. |
BUY
Open market or private purchase
|
Indirect |
333,333
+27.43%
|
$4,999,995
$15.0 P/Share
|
|
Sep 12
2025
|
Vida Ventures Gp Iii, L.L.C. |
BUY
Conversion of derivative security
|
Indirect |
548,910
+50.0%
|
-
|